Study on Eczema on Homoeopathic study

A CLINICAL STUDY ON THE HOMOEOPATHIC MANAGEMENT OF ECZEMA USING SYNTHESIS REPERTORY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/114194

Enrollment

Registered

2026-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Individualized homoeopathic treatment: Selected by the individualized case taking Dose and potency will be selected according to the susceptibility of the patient and administration by

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed with Eczema. Pre diagnosed cases of Eczema or newly added cases fulfilling Hannifin and Rajka criteria. Willing to provide informed consent for participation and optional image use. Patient of all socioeconomic class.

Exclusion criteria

Exclusion criteria: Patient with critical systemic Illness or serious pathological conditions. Pregnant and Lactating women. Patient taking other therapeutics measures for Eczema

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of individualized homoeopathic treatment in management of Eczema using the Synthesis repertory and Assessment through EASI scale.Timepoint: 15 days	—

Secondary

Measure	Time frame
To evaluate the most common rubics and medicines which are used for Eczema using Synthesis Repertory 9.1Timepoint: 15 days	—

Countries

India

Contacts

Public Contactdr kanan bhatt

rajkot homoeopathic medical college

kanan.bhatt20929@paruluniversity.ac.in9426143656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026